These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 31543505)

  • 41. Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.
    Maphis N; Xu G; Kokiko-Cochran ON; Jiang S; Cardona A; Ransohoff RM; Lamb BT; Bhaskar K
    Brain; 2015 Jun; 138(Pt 6):1738-55. PubMed ID: 25833819
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Memory deficits correlate with tau and spine pathology in P301S MAPT transgenic mice.
    Xu H; Rösler TW; Carlsson T; de Andrade A; Bruch J; Höllerhage M; Oertel WH; Höglinger GU
    Neuropathol Appl Neurobiol; 2014 Dec; 40(7):833-43. PubMed ID: 24865638
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chronic Sleep Disruption Advances the Temporal Progression of Tauopathy in P301S Mutant Mice.
    Zhu Y; Zhan G; Fenik P; Brandes M; Bell P; Francois N; Shulman K; Veasey S
    J Neurosci; 2018 Nov; 38(48):10255-10270. PubMed ID: 30322903
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice.
    Hastings NB; Wang X; Song L; Butts BD; Grotz D; Hargreaves R; Fred Hess J; Hong KK; Huang CR; Hyde L; Laverty M; Lee J; Levitan D; Lu SX; Maguire M; Mahadomrongkul V; McEachern EJ; Ouyang X; Rosahl TW; Selnick H; Stanton M; Terracina G; Vocadlo DJ; Wang G; Duffy JL; Parker EM; Zhang L
    Mol Neurodegener; 2017 May; 12(1):39. PubMed ID: 28521765
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quercetagitrin Inhibits Tau Accumulation and Reverses Neuroinflammation and Cognitive Deficits in P301S-Tau Transgenic Mice.
    Zhong S; Ye J; Deng Y; Zhang M; Zou M; Yao X; Xiao S
    Molecules; 2023 May; 28(9):. PubMed ID: 37175376
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Motifs in the tau protein that control binding to microtubules and aggregation determine pathological effects.
    Lathuilière A; Valdés P; Papin S; Cacquevel M; Maclachlan C; Knott GW; Muhs A; Paganetti P; Schneider BL
    Sci Rep; 2017 Oct; 7(1):13556. PubMed ID: 29051562
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Conformation determines the seeding potencies of native and recombinant Tau aggregates.
    Falcon B; Cavallini A; Angers R; Glover S; Murray TK; Barnham L; Jackson S; O'Neill MJ; Isaacs AM; Hutton ML; Szekeres PG; Goedert M; Bose S
    J Biol Chem; 2015 Jan; 290(2):1049-65. PubMed ID: 25406315
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of forebrain BIN1 attenuates hippocampal pathology and neuroinflammation in a tauopathy model.
    Ponnusamy M; Wang S; Yuksel M; Hansen MT; Blazier DM; McMillan JD; Zhang X; Dammer EB; Collier L; Thinakaran G
    Brain; 2023 Apr; 146(4):1561-1579. PubMed ID: 36059072
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TFEB Overexpression in the P301S Model of Tauopathy Mitigates Increased PHF1 Levels and Lipofuscin Puncta and Rescues Memory Deficits.
    Wang H; Wang R; Carrera I; Xu S; Lakshmana MK
    eNeuro; 2016; 3(2):. PubMed ID: 27257626
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assembly of transgenic human P301S Tau is necessary for neurodegeneration in murine spinal cord.
    Macdonald JA; Bronner IF; Drynan L; Fan J; Curry A; Fraser G; Lavenir I; Goedert M
    Acta Neuropathol Commun; 2019 Mar; 7(1):44. PubMed ID: 30885267
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kinesin-1 transport reductions enhance human tau hyperphosphorylation, aggregation and neurodegeneration in animal models of tauopathies.
    Falzone TL; Gunawardena S; McCleary D; Reis GF; Goldstein LS
    Hum Mol Genet; 2010 Nov; 19(22):4399-408. PubMed ID: 20817925
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complement C3a receptor antagonist alleviates tau pathology and ameliorates cognitive deficits in P301S mice.
    Yao Y; Chang Y; Li S; Zhu J; Wu Y; Jiang X; Li L; Liu R; Ma R; Li G
    Brain Res Bull; 2023 Aug; 200():110685. PubMed ID: 37330021
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Repetitive Traumatic Brain Injury Causes Neuroinflammation before Tau Pathology in Adolescent P301S Mice.
    Izzy S; Brown-Whalen A; Yahya T; Sarro-Schwartz A; Jin G; Chung JY; Lule S; Morsett LM; Alquraini A; Wu L; Hickman SE; Whalen MJ; El Khoury J
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477535
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PM2.5 triggers tau aggregation in a mouse model of tauopathy.
    Liu C; Meng L; Gao Y; Chen J; Zhu M; Xiong M; Xiao T; Gu X; Liu C; Li T; Zhang Z
    JCI Insight; 2024 Jul; 9(14):. PubMed ID: 39133647
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perineuronal net digestion with chondroitinase restores memory in mice with tau pathology.
    Yang S; Cacquevel M; Saksida LM; Bussey TJ; Schneider BL; Aebischer P; Melani R; Pizzorusso T; Fawcett JW; Spillantini MG
    Exp Neurol; 2015 Mar; 265():48-58. PubMed ID: 25483398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cornel Iridoid Glycoside Suppresses Hyperactivity Phenotype in rTg4510 Mice through Reducing Tau Pathology and Improving Synaptic Dysfunction.
    Ma DL; Luo Y; Huang R; Zhao ZR; Zhang L; Li YL; Wang Q; Li L; Zhang L
    Curr Med Sci; 2020 Dec; 40(6):1031-1039. PubMed ID: 33428130
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development and characterization of novel anti-acetylated tau monoclonal antibodies to probe pathogenic tau species in Alzheimer's disease.
    Bryan Iii MR; Tian X; Tseng JH; Evangelista BA; Ragusa JV; Bryan AF; Trotman W; Irwin D; Cohen TJ
    Acta Neuropathol Commun; 2024 Oct; 12(1):163. PubMed ID: 39396065
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protein Semisynthesis Provides Access to Tau Disease-Associated Post-translational Modifications (PTMs) and Paves the Way to Deciphering the Tau PTM Code in Health and Diseased States.
    Haj-Yahya M; Lashuel HA
    J Am Chem Soc; 2018 May; 140(21):6611-6621. PubMed ID: 29684271
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.
    Javidnia M; Hebron ML; Xin Y; Kinney NG; Moussa CE
    J Alzheimers Dis; 2017; 60(2):461-481. PubMed ID: 28869476
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phospho-Tau Accumulation and Structural Alterations of the Golgi Apparatus of Cortical Pyramidal Neurons in the P301S Tauopathy Mouse Model.
    Antón-Fernández A; Merchán-Rubira J; Avila J; Hernández F; DeFelipe J; Muñoz A
    J Alzheimers Dis; 2017; 60(2):651-661. PubMed ID: 28922155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.